Bausch Health Companies (BHC) Change in Receivables (2009 - 2026)

Bausch Health Companies has disclosed Change in Receivables across 18 years of filings, most recently posting -$148.0 million for Q1 2026.

• Change in Receivables for Q1 2026 came in at -$148.0 million, down 34.55% year-over-year; the trailing twelve-month figure through Mar 2026 was $96.0 million (up 123.26% YoY), and the FY2025 annual result was $134.0 million, down 37.96% from the prior year.
• Change in Receivables came in at -$148.0 million for Q1 2026 at Bausch Health Companies, down from -$65.0 million in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $231.0 million in Q3 2023 to a low of -$197.0 million in Q1 2022.
• The 5-year median for Change in Receivables is $53.0 million (2023), against an average of $26.7 million.
• Peak annual rise in Change in Receivables reached 1047.83% in 2025, while the deepest fall reached 274.6% in 2025.
• Bausch Health Companies' Change in Receivables stood at $31.0 million in 2022, then plunged by 38.71% to $19.0 million in 2023, then jumped by 447.37% to $104.0 million in 2024, then slumped by 162.5% to -$65.0 million in 2025, then plunged by 127.69% to -$148.0 million in 2026.
• The last three Change in Receivables figures came in at -$148.0 million (Q1 2026), -$65.0 million (Q4 2025), and $218.0 million (Q3 2025), per Business Quant data.